| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5985864 | EISAI INC | Polymorphs of donepezil hydrochloride and process for production |
Dec, 2016
(7 years ago) | |
| US6140321 | EISAI INC | Polymorphs of donepezil hydrochloride and process for production |
Dec, 2016
(7 years ago) | |
| US6245911 | EISAI INC | Donepezil polycrystals and process for producing the same |
Dec, 2018
(5 years ago) | |
| US8481565 | EISAI INC | Method for stabilizing anti-dementia drug |
Oct, 2026
(2 years from now) | |
Aricept is owned by Eisai Inc.
Aricept contains Donepezil Hydrochloride.
Aricept has a total of 4 drug patents out of which 3 drug patents have expired.
Expired drug patents of Aricept are:
- US5985864
- US6140321
- US6245911
Aricept was authorised for market use on 25 November, 1996.
Aricept is available in tablet;oral dosage forms.
The generics of Aricept are possible to be released after 04 October, 2026.
Drugs and Companies using DONEPEZIL HYDROCHLORIDE ingredient
Market Authorisation Date: 25 November, 1996
Treatment: NA
Dosage: TABLET;ORAL
How can I launch a generic of ARICEPT before it's drug patent expiration?
More Information on Dosage
ARICEPT family patents
